Editor's note: A previous version of this story used preliminary numbers showing a 17.6% YOY decrease for March. Final numbers from Motor Intelligence show a 3.4% increase. The story has been updated to reflect these numbers. The Fool regrets the error.
Domestic market sales for passenger vehicles and light trucks increased 3.4% year-over-year for March, according to a Motor Intelligence report released today.
Of the 21 automakers included in the analysis, Subaru sales increased the most (+13.3%), followed by BMW's 11.2% bump. General Motors (NYSE:GM) managed a 6.4% rise, Ford (NYSE:F) pulled in 5.7% more sales, and Toyota Motor (NYSE:TM) squeaked by with a 1% increase. Volvo sales fell 19.8%.
For calendar year-to-date sales, Ferrari has managed the largest sales increase (+18.9%). General Motors, Ford, and Toyota have all seen double-digit percentage increases in light truck sales, even as passenger vehicle sales increases remain in single-digit territory.
Motor Intelligence is part of Autodata Corp., providing automotive statistical data, market intelligence, and analysis.
Fool contributor Justin Loiseau has no position in any stocks mentioned, although he wishes he could contribute to Ferrari's year-to-date sales increase. You can follow him on Twitter, @TMFJLo, and on Motley Fool CAPS, @TMFJLo.
The Motley Fool recommends Ford and General Motors. The Motley Fool owns shares of Ford. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What Happened in the Stock Market Today
Stocks had a huge day, sending the major indexes to new records. Shares of Juno Therapeutics soared following a buyout report, and Ford slumped on disappointing guidance.
Why Shares of Ford Motor Company Fell 7% Today
Ford's 2018 guidance didn't sit well with investors.
Ford's Behind-the-Scenes Focus on Data
Ford’s recent partnerships and small-scale tests could bode well for the future.